Does evaluation with the International Prostate Symptom Score predict the outcome of transurethral resection of the prostate?
PURPOSE: We determined the reliability of the International Prostate Symptom Score (I-PSS) in predicting the outcome of transurethral prostatectomy and, therefore, how useful it can be in patient selection for surgery. MATERIALS AND METHODS: A prospective trial was done of 105 consecutive patients undergoing transurethral prostatectomy at our institution. Patients were assessed with the I-PSS before and 3 months after surgery. Flow rates and preoperative residual volumes also were measured. RESULTS: There was significant postoperative improvement in all parameters of the symptom score and a change in symptom profile. Symptoms remaining with the greatest scores at 3 months postoperatively were frequency, urgency and nocturia. A significant correlation was found between I-PSS and quality of life before and after transurethral prostatectomy, and between postoperative improvement in flow rates and change in I-PSS. Patients with a greater preoperative I-PSS gained the most symptomatic benef
Related Questions
- Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate?
- Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
- Can the outcome of transurethral resection of the prostate be predicted preoperatively?
